07 May 2013, BioSpectrum Bureau , BioSpectrum
Singapore: The American College of Chest Physicians (ACCP) has recommended that people, who are being screened for lung cancer and already face a significant risk of lung cancer due to age and smoking history, should be scanned using only low-dose computed tomography (LDCT).
The recommendation has been made by the ACCP in its third edition of evidence-based lung cancer guidelines titled 'Diagnosis and Management of Lung Cancer: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines'.
The guidelines cite evidence to show lung cancer screening, through a structured and specific protocol, can reduce lung cancer deaths among individuals who are at elevated risk of developing lung cancer. The guidelines also document the advances made over the past five years in the treatment of tobacco use, including the benefits of tobacco cessation programs, in patients with lung cancer. The most effective deterrent to acquiring lung cancer is avoidance of tobacco products.
The guidelines call for the establishment of a registry designed to help address the large number of unanswered questions that arise as screening is implemented, as well as to clarify frequent misconceptions around lung cancer screening among patients and physicians. Additionally, the guidelines call for establishment of quality metrics so that benefits are optimized, and harm is kept low.
Dr W Michael Alberts of the Moffitt Cancer Center, US, and chair of the guideline panel, said that, "Our new lung cancer guidelines take into account the many advances and new information in the field by providing comprehensive and nuanced recommendations related to prevention, screening, diagnosis, staging, and medical and surgical treatments. It also showcases the importance of multidisciplinary, team-based care when it comes to effective lung cancer treatment-collaborative decisions based on collective knowledge provide the most comprehensive patient-focused care."